Novartis AG (NVS) – Bullish Recovery with Key Levels to WatchAnalysis Overview:
Novartis AG has shown a strong recovery, bouncing back from its recent low near $91.84, a key support level that held well. The stock is now trading at $103.29 (+3.32%), approaching its mid-term moving averages, signaling renewed momentum.
Key Levels:
Support: $91.84 (Strong bas
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
6.30 EUR
11.53 B EUR
48.58 B EUR
About Novartis AG
Sector
Industry
CEO
Vasant Narasimhan
Website
Headquarters
Basel
Founded
1996
Identifiers
3
ISINUS66987V1098
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
NVS6224266
Novartis Capital Corp. 5.3% 05-NOV-2055Yield to maturity
5.52%
Maturity date
Nov 5, 2055
NVS5894401
Novartis Capital Corp. 4.7% 18-SEP-2054Yield to maturity
5.40%
Maturity date
Sep 18, 2054
NVS6224265
Novartis Capital Corp. 5.2% 05-NOV-2045Yield to maturity
5.38%
Maturity date
Nov 5, 2045
US66989HAH1
Novartis Capital Corp. 4.4% 06-MAY-2044Yield to maturity
5.37%
Maturity date
May 6, 2044
XPND
Novartis Capital Corp. 4.0% 20-NOV-2045Yield to maturity
5.37%
Maturity date
Nov 20, 2045
NVS3904288
Novartis Capital Corp. 3.7% 21-SEP-2042Yield to maturity
5.24%
Maturity date
Sep 21, 2042
NVS6224264
Novartis Capital Corp. 4.6% 05-NOV-2035Yield to maturity
4.72%
Maturity date
Nov 5, 2035
NVS5894400
Novartis Capital Corp. 4.2% 18-SEP-2034Yield to maturity
4.52%
Maturity date
Sep 18, 2034
NVS6224263
Novartis Capital Corp. 4.3% 05-NOV-2032Yield to maturity
4.36%
Maturity date
Nov 5, 2032
NVS5894399
Novartis Capital Corp. 4.0% 18-SEP-2031Yield to maturity
4.10%
Maturity date
Sep 18, 2031
NVS6224251
Novartis Capital Corp. 4.1% 05-NOV-2030Yield to maturity
4.09%
Maturity date
Nov 5, 2030
See all NOTA bonds
HHL.B
Harvest Healthcare Leaders Income ETF Trust Units B UnhedgedWeight
5.02%
Market value
65.48 M
USD
Explore more ETFs
Curated watchlists where NOTA is featured.


